123 related articles for article (PubMed ID: 1394642)
1. Effect of cyclodextrins on biological membrane. II. Mechanism of enhancement on the intestinal absorption of non-absorbable drug by cyclodextrins.
Nakanishi K; Nadai T; Masada M; Miyajima K
Chem Pharm Bull (Tokyo); 1992 May; 40(5):1252-6. PubMed ID: 1394642
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyclodextrins on biological membrane. I. Effect of cyclodextrins on the absorption of a non-absorbable drug from rat small intestine and rectum.
Nakanishi K; Nadai T; Masada M; Miyajima K
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1684-7. PubMed ID: 2208383
[TBL] [Abstract][Full Text] [Related]
3. Release characteristics of endogenous constituents by exposure of small intestine to modified beta-cyclodextrins.
Tanino T; Ogiso T; Iwaki M; Yamaguchi T; Kakehi K
Biol Pharm Bull; 1999 Oct; 22(10):1099-105. PubMed ID: 10549863
[TBL] [Abstract][Full Text] [Related]
4. Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository.
Arima H; Kondo T; Irie T; Uekama K
J Pharm Sci; 1992 Nov; 81(11):1119-25. PubMed ID: 1447717
[TBL] [Abstract][Full Text] [Related]
5. Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits.
Watanabe Y; Matsumoto Y; Seki M; Takase M; Matsumoto M
Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3042-7. PubMed ID: 1477920
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K
J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
[TBL] [Abstract][Full Text] [Related]
7. Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits.
Watanabe Y; Matsumoto Y; Kawamoto K; Yazawa S; Matsumoto M
Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3100-4. PubMed ID: 1477928
[TBL] [Abstract][Full Text] [Related]
8. Effect of sugar-modified beta-cyclodextrins on dissolution and absorption characteristics of phenytoin.
Tanino T; Ogiso T; Iwaki M
Biol Pharm Bull; 1999 Mar; 22(3):298-304. PubMed ID: 10220288
[TBL] [Abstract][Full Text] [Related]
9. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
Arima H; Yunomae K; Hirayama F; Uekama K
J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
[TBL] [Abstract][Full Text] [Related]
10. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H
Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706
[TBL] [Abstract][Full Text] [Related]
11. [Use of water-soluble beta-cyclodextrin derivatives as carriers of anti-inflammatory drug biphenylylacetic acid in rectal delivery].
Arima H; Kondo T; Irie T; Hirayama F; Uekama K; Miyaji T; Inoue Y
Yakugaku Zasshi; 1992 Jan; 112(1):65-72. PubMed ID: 1578346
[TBL] [Abstract][Full Text] [Related]
12. Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment.
Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):582-6. PubMed ID: 8882455
[TBL] [Abstract][Full Text] [Related]
13. A study of the percutaneous absorption-enhancing effects of cyclodextrin derivatives in rats.
Vollmer U; Müller BW; Peeters J; Mesens J; Wilffert B; Peters T
J Pharm Pharmacol; 1994 Jan; 46(1):19-22. PubMed ID: 8201522
[TBL] [Abstract][Full Text] [Related]
14. Experimental, molecular docking investigations and bioavailability study on the inclusion complexes of finasteride and cyclodextrins.
Mady FM; Farghaly Aly U
Drug Des Devel Ther; 2017; 11():1681-1692. PubMed ID: 28652706
[TBL] [Abstract][Full Text] [Related]
15. A moderate interaction of maltosyl-alpha-cyclodextrin with Caco-2 cells in comparison with the parent cyclodextrin.
Ono N; Arima H; Hirayama F; Uekama K
Biol Pharm Bull; 2001 Apr; 24(4):395-402. PubMed ID: 11305602
[TBL] [Abstract][Full Text] [Related]
16. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):884-93. PubMed ID: 16226752
[TBL] [Abstract][Full Text] [Related]
17. Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities.
Yoshida A; Yamamoto M; Irie T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1059-63. PubMed ID: 2766408
[TBL] [Abstract][Full Text] [Related]
18. Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro.
Irie T; Otagiri M; Sunada M; Uekama K; Ohtani Y; Yamada Y; Sugiyama Y
J Pharmacobiodyn; 1982 Sep; 5(9):741-4. PubMed ID: 7153847
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of modified beta-cyclodextrins on pharmacological activity and bioavailability of 4-biphenylacetic acid in rats after oral administration.
Puglisi G; Ventura CA; Spadaro A; Campana G; Spampinato S
J Pharm Pharmacol; 1995 Feb; 47(2):120-3. PubMed ID: 7602465
[TBL] [Abstract][Full Text] [Related]
20. Enhanced absorption of cyclosporin A by complexation with dimethyl-beta-cyclodextrin in bile duct-cannulated and -noncannulated rats.
Miyake K; Arima H; Irie T; Hirayama F; Uekama K
Biol Pharm Bull; 1999 Jan; 22(1):66-72. PubMed ID: 9989664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
